Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Nneka Ufere

Liver Transplant · MGH

View

Dr. Vinay Jahagirdar

Liver Transplant · Medical College of Virginia

View

Dr. Lauren Feld

Liver Transplant · UMass Memorial

View

Dr. Sonali Paul

Liver Transplant · UCMC

View

Dr. Pierre Gholam

Liver Transplant · CWRU

View

Dr. Elliot Tapper

Liver Transplant · UM

View

Dr. Saurabh Sethi

General GI · Oja Health

View

Dr. Sara Horst

IBD · Vanderbilt

View

Dr. Wendi LeBrett

General GI · ModernGut

View

Dr. Treta Purohit

General GI · Oshi Health

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms

    Overview

    Psychosocial therapy improves outcomes for alcohol use disorder in people with chronic liver disease: A systematic review and meta-analysis.

    Sep 22, 2025DOI: 10.1097/hc9.0000000000000805Journal ArticleHepatology Communications

    Written by: Christopher H SollenbergerHuai-En R ChangJonathan LimMohammed Rifat ShaikHanna BlaneyVaishnavi MathurNancy TerryJeremy W LukNancy DiazgranadosChristine C Hsu

    Find these authors on Roon

    HB
    Dr. Hanna Blaney
    Liver Transplant · Medical College of Virginia
    BACKGROUND: Psychosocial interventions are effective for alcohol use disorder (AUD), but their impact on patients with chronic liver disease and AUD remains unclear. This systematic review and meta-analysis evaluated the effectiveness of psychosocial therapies in preventing return-to-drinking and promoting abstinence among this population.METHODS AND RESULTS: The protocol (CRD42024527757) was registered in Prospero. We included studies involving adults (≥18 y) with chronic liver disease and AUD or harmful alcohol use receiving psychosocial interventions. Databases searched were PubMed, Embase, Cochrane CENTRAL, and APA PsycInfo. Outcomes assessed were return-to-drinking and abstinence. Risk of bias was evaluated using RoB2 for randomized controlled trials (RCTs) and ROBINS-I for non-RCTs. Meta-analysis was performed using random effects (Knap-Hartung adjustment) and fixed effects (inverse variance) models. Funding was provided by the intramural research program at the National Institute of Diabetes and Digestive and Kidney Diseases. Of 2240 studies reviewed, 20 met the inclusion criteria. Meta-analysis of 7 non-RCTs (n=767) demonstrated a 48% reduction in return-to-drinking risk (relative risk [RR]=0.52, 95% CI: 0.28-0.99, p=0.048) with significant heterogeneity (I2=74%; p=0.006). Subgroup analyses showed greater return-to-drinking reduction in multidisciplinary care (RR=0.40, 95% CI: 0.31-0.52) and recipients of liver transplant (RR=0.40, 95% CI: 0.27-0.58). Four RCTs found no significant return-to-drinking reduction (RR=0.99, 95% CI: 0.45-2.16, p=0.96). Abstinence was not significantly improved in either RCTs or non-RCTs, with moderate- to low-quality evidence.CONCLUSIONS: Psychosocial therapy reduces return-to-drinking risk in chronic liver disease with AUD, particularly within multidisciplinary teams or transplant populations, but findings are tempered by scarce RCT evidence. Future RCTs should evaluate multidisciplinary interventions in transplant populations.
    HBDr. Hanna Blaney

    Dr. Hanna Blaney

    Gastroenterology · Hepatology & Liver Transplantation
    Virginia Commonwealth University Medical Center
    hannab